Metformin and glibenclamide: comparative risks.
作者信息
Campbell I W
出版信息
Br Med J (Clin Res Ed). 1984 Aug 4;289(6440):289. doi: 10.1136/bmj.289.6440.289.
Abstract
摘要
相似文献
1
Metformin and glibenclamide: comparative risks.二甲双胍与格列本脲：比较风险
Br Med J (Clin Res Ed). 1984 Aug 4;289(6440):289. doi: 10.1136/bmj.289.6440.289.
2
Metformin and the sulphonylureas: the comparative risk.
Horm Metab Res Suppl. 1985;15:105-11.
3
Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.奥曲肽：一种治疗难治性磺脲类药物所致低血糖症的新疗法。
Pancreas. 2013 May;42(4):722-3. doi: 10.1097/MPA.0b013e3182769c26.
4
[Diabetes treatment in patients with chronic kidney disease].[慢性肾脏病患者的糖尿病治疗]
Dtsch Med Wochenschr. 2013 May;138(21):1109-18; quiz 1119-22. doi: 10.1055/s-0032-1332954. Epub 2013 May 15.
5
Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.格列美脲/二甲双胍联合治疗与格列本脲/二甲双胍治疗控制不佳的 2 型糖尿病患者的疗效。
J Diabetes Complications. 2009 Nov-Dec;23(6):376-9. doi: 10.1016/j.jdiacomp.2008.09.002. Epub 2008 Oct 11.
6
The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.格列本脲（glyburide）与改良释放格列齐特（gliclazide）的低血糖风险比较。
Can J Diabetes. 2015 Aug;39(4):308-16. doi: 10.1016/j.jcjd.2015.01.001. Epub 2015 Mar 31.
7
[Coma in type 2 diabete mellitus on metformin treatment].[接受二甲双胍治疗的2型糖尿病患者昏迷]
Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):84-7.
8
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.一项开放、随机、平行组研究，旨在比较吸入型人胰岛素（依克那肽）与格列本脲作为辅助治疗对二甲双胍治疗效果不佳的2型糖尿病患者的疗效和安全性。
Diabetes Care. 2006 Aug;29(8):1818-25. doi: 10.2337/dc05-1880.
9
10
[Glibenclamide (Maninil)-induced hypoglycemia--a case report].[格列本脲（美吡达）诱发的低血糖——病例报告]
Z Arztl Fortbild (Jena). 1988;82(3):139-40.
引用本文的文献
1
Changes in metformin use in chronic kidney disease.慢性肾脏病中二甲双胍使用情况的变化
Clin Kidney J. 2017 Jun;10(3):301-304. doi: 10.1093/ckj/sfx017. Epub 2017 Mar 28.
2
Effects of Metformin and a Mammalian Target of Rapamycin (mTOR) ATP-Competitive Inhibitor on Targeted Metabolomics in Pancreatic Cancer Cell Line.二甲双胍和雷帕霉素哺乳动物靶点（mTOR）ATP竞争性抑制剂对胰腺癌细胞系靶向代谢组学的影响。
Metabolomics (Los Angel). 2016;6(3). doi: 10.4172/2153-0769.1000183. Epub 2016 Aug 20.
3
Drug administration in patients with diabetes mellitus. Safety considerations.糖尿病患者的药物给药。安全考量。
Drug Saf. 1998 Jun;18(6):441-55. doi: 10.2165/00002018-199818060-00005.
4
[Value of biguanide in therapy of diabetes mellitus].[双胍类药物在糖尿病治疗中的价值]
Med Klin (Munich). 1997 Aug 15;92(8):472-9, 505. doi: 10.1007/BF03044916.
5
Metformin-associated lactic acidosis in Sweden 1977-1991.1977 - 1991年瑞典的二甲双胍相关性乳酸酸中毒
Eur J Clin Pharmacol. 1993;44(6):589-91. doi: 10.1007/BF02440866.
6
Features, prevention and management of acute overdose due to antidiabetic drugs.
Drug Saf. 1993 Sep;9(3):218-29. doi: 10.2165/00002018-199309030-00007.
7
Comparative tolerability profiles of oral antidiabetic agents.口服抗糖尿病药物的耐受性比较概况
Drug Saf. 1994 Oct;11(4):223-41. doi: 10.2165/00002018-199411040-00002.
8
Sulphonylureas and hypoglycaemia.磺脲类药物与低血糖症
Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):949-50. doi: 10.1136/bmj.296.6627.949.
9
Treatment of type II diabetes.II型糖尿病的治疗。
Br Med J (Clin Res Ed). 1986 May 10;292(6530):1273-4. doi: 10.1136/bmj.292.6530.1273-b.
本文引用的文献
1
Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function.
Acta Med Scand. 1981;209(6):519-20. doi: 10.1111/j.0954-6820.1981.tb11639.x.
2
The status of metformin in Canada.二甲双胍在加拿大的情况。
Can Med Assoc J. 1983 Jan 1;128(1):24-6.
3
Glibenclamide-associated hypoglycaemia: a report on 57 cases.格列本脲相关性低血糖症：57例报告
Diabetologia. 1983 Jun;24(6):412-7. doi: 10.1007/BF00257338.
Zotero 插件